Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV004799396 | SCV001432864 | likely pathogenic | Neurodevelopmental disorder with or without early-onset generalized epilepsy | 2020-02-11 | criteria provided, single submitter | clinical testing | The c.3894CA,p.Asp1298Glu missense variant in the NBEA gene has not been reported in the available literature. The variant is absent from the gnomAD database, indicating this is a rare allele. In silico tools, SIFT, PolyPhen, REVEL, and CADD predict conflicting evidence of pathogenicity [https://useast.ensembl.org/info/docs/tools/vep/index.html]. Based on the available evidence, the de novo c.3894C>A,p.Asp1298Glu variant in the NBEA gene is classified as likely pathogenic. |